Kubvumbi 2023: Retifanlimab-dlwr (Zynyz, Incyte Corporation) yakagamuchira mvumo yekukurumidza kubva kuFood and Drug Administration yekurapa varwere vakuru vane metastatic kana inowanzoitika munharaunda Merkel cell cancer (MCC). MuPODIUM-2..